ArticlePakistan journal of medical sciences2026
Relationship of ABO blood groups with metabolic syndrome and its metabolic abnormalities in a population in North Lahore.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To examine the relationship of ABO blood groups with metabolic syndrome (MetS) and its metabolic abnormalities in an urban population in Lahore. Methodology: A cross-sectional study was carried out at the Department of Life Sciences, University of Management and Technology, Lahore from August 2022 to August 2024 on 890 healthy subjects recruited from localities in Northern Lahore with informed consent. Blood samples were analyzed for ABO blood groups and three metabolic abnormalities, namely: fasting hyperglycemia, hypertriglyceridemia and low HDL cholesterol. In addition, central obesity and blood pressure were determined. A brief questionnaire covering demographic characteristics was also administered. Chi-square test and logistic regression were used for determining the association between ABO blood groups and MetS and its metabolic abnormalities. Results: Adults from 18 years to 75 years had a Mean ± SD age of 40.87±11.84 years. Percentages of A, B, AB and O blood groups were 22%, 41%, 11% and 26%, respectively. No association was found between ABO blood groups and MetS (p-value=0.88), however the adjusted odds of having hypertriglyceridemia in blood group A subjects was 1.8 times higher compared to subjects with blood group AB [AOR: 1.80; 95% CI: 1.02-3.18]. Conclusion: There was a lack of association between ABO blood groups and MetS. Blood group A individuals appear more vulnerable to having hypertriglyceridemia in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.